Login to Your Account

MiddleBrook Soars on FDA OK of Once-Daily Strep Antibiotic

By Donna Young

Friday, January 25, 2008
MiddleBrook Pharmaceuticals Inc.'s stock skyrocketed Thursday after the FDA approved its once-daily, extended-release amoxicillin tablet, Moxatag. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription